tetano
Editor, Senior Moderator
J Cardiovasc Dev Dis
. 2022 Sep 2;9(9):292.
doi: 10.3390/jcdd9090292.
Effects of COVID-19 on Arrhythmia
Yujia Zhan[SUP] 1 [/SUP], Honghua Yue[SUP] 1 [/SUP], Weitao Liang[SUP] 1 [/SUP], Zhong Wu[SUP] 1 [/SUP]
Affiliations
Abstract
The World Health Organization announced that COVID-19, with SARS-CoV-2 as its pathogen, had become a pandemic on 11 March 2020. Today, the global epidemic situation is still serious. With the development of research, cardiovascular injury in patients with COVID-19, such as arrhythmia, myocardial injury, and heart failure, is the second major symptom in addition to respiratory symptoms, and cardiovascular injury is related to the prognosis and mortality of patients. The incidence of arrhythmia in COVID-19 patients ranges from 10% to 20%. The potential mechanisms include viral infection-induced angiotensin-converting enzyme 2 expression change, myocarditis, cytokine storm, cardiac injury, electrophysiological effects, hypoxemia, myocardial strain, electrolyte abnormalities, intravascular volume imbalance, drug toxicities and interactions, and stress response caused by virus infection. COVID-19 complicated with arrhythmia needs to be accounted for and integrated in management. This article reviews the incidence, potential mechanisms, and related management measures of arrhythmia in COVID-19 patients.
Keywords: COVID-19; SARS-CoV-2; arrhythmia; cardiovascular disease; coronavirus.
. 2022 Sep 2;9(9):292.
doi: 10.3390/jcdd9090292.
Effects of COVID-19 on Arrhythmia
Yujia Zhan[SUP] 1 [/SUP], Honghua Yue[SUP] 1 [/SUP], Weitao Liang[SUP] 1 [/SUP], Zhong Wu[SUP] 1 [/SUP]
Affiliations
- PMID: 36135437
- DOI: 10.3390/jcdd9090292
Abstract
The World Health Organization announced that COVID-19, with SARS-CoV-2 as its pathogen, had become a pandemic on 11 March 2020. Today, the global epidemic situation is still serious. With the development of research, cardiovascular injury in patients with COVID-19, such as arrhythmia, myocardial injury, and heart failure, is the second major symptom in addition to respiratory symptoms, and cardiovascular injury is related to the prognosis and mortality of patients. The incidence of arrhythmia in COVID-19 patients ranges from 10% to 20%. The potential mechanisms include viral infection-induced angiotensin-converting enzyme 2 expression change, myocarditis, cytokine storm, cardiac injury, electrophysiological effects, hypoxemia, myocardial strain, electrolyte abnormalities, intravascular volume imbalance, drug toxicities and interactions, and stress response caused by virus infection. COVID-19 complicated with arrhythmia needs to be accounted for and integrated in management. This article reviews the incidence, potential mechanisms, and related management measures of arrhythmia in COVID-19 patients.
Keywords: COVID-19; SARS-CoV-2; arrhythmia; cardiovascular disease; coronavirus.